about
Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium.Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian EpitheliumMaternal Cdx2 is dispensable for mouse development.Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene.Cyanoacrylate Associated Foreign Body Granulomatous Gastritis: A Report of Three Cases.CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium.Histopathological evaluation of orchiectomy specimens in 51 late postpubertal men with unilateral cryptorchidism.Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.Morphologic and Immunohistochemical Appraisal of Primary Gastric Carcinomas.Image of the Month: A Neuroendocrine Tumor Invading All Portal Venous System Components.Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists.Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis.Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivationA Highly Potent TACC3 Inhibitor as a Novel Anti-cancer Drug CandidateThe potential efficacy of dietary fatty acids and fructose induced inflammation and oxidative stress on the insulin signaling and fat accumulation in miceAn immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissuesClass III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response
P50
Q34603673-CDA99358-9955-4D21-9EBA-3473C0B2FA80Q35157655-9D756694-00E2-4E71-A932-10F6FD0C7699Q35830331-85961127-E9E7-4F16-83F7-E451B5D79F75Q36321343-560B104D-FFF7-4C81-9F59-C170BF8BEB02Q36517795-99AAE00B-0731-46A6-9E9D-7ECAEE64134EQ37620214-4E501717-FCA5-40FC-99EB-21483CF62D92Q40436313-74C00204-40E6-42F3-AC6D-B6A4D403A136Q42459177-E01E95DC-7EAC-4CF7-86BD-D9841C19D0A7Q48120168-8CF56B36-C57C-4F7F-B4AB-A7E2864405C6Q50042676-58D72F44-C1A8-409F-BF1B-24E5FFA083A4Q52984090-04FBAF63-D07F-4DB0-BE1A-001CBBC53DA1Q53095157-8FDC15F2-EABA-4D65-B5B7-44CEF8009C15Q54365026-A973F4BE-0AC0-48B0-9538-5FD7B5B1A6CCQ54443542-FFD02A76-B10D-49F0-A82C-856D8ACED7F5Q81454513-81857A8F-5F9F-4B34-80FD-C98170B9A56AQ90689892-D5DC7A1C-1764-4E6B-8B49-D648C9E351C7Q91042561-1D79A225-825B-48EF-82ED-F07FA86928BCQ91276869-8E0E6426-AEED-4DB7-97BD-029D5399859BQ91318617-FCF11FE1-C15C-4DAA-9B15-85E675C00A28
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Aytekin Akyol
@ast
Aytekin Akyol
@en
Aytekin Akyol
@es
Aytekin Akyol
@nl
Aytekin Akyol
@sl
type
label
Aytekin Akyol
@ast
Aytekin Akyol
@en
Aytekin Akyol
@es
Aytekin Akyol
@nl
Aytekin Akyol
@sl
prefLabel
Aytekin Akyol
@ast
Aytekin Akyol
@en
Aytekin Akyol
@es
Aytekin Akyol
@nl
Aytekin Akyol
@sl
P106
P31
P496
0000-0002-4075-3475